Scilex Holding Co. (SCLX)
9.00
+0.91
(+11.25%)
USD |
NASDAQ |
Mar 03, 16:00
8.51
-0.49
(-5.44%)
After-Hours: 20:00
Scilex EPS Diluted (Quarterly) : -22.17 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Plus Therapeutics, Inc. | -0.0412 |
| BioStem Technologies, Inc. | 0.0328 |
| Iovance Biotherapeutics, Inc. | -0.1767 |
| Protokinetix, Inc. | -0.0002 |
| GB Sciences, Inc. | -0.0002 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -257.82M |
| Revenue (Quarterly) | 10.56M |
| Total Expenses (Quarterly) | 267.79M |
| Enterprise Value | 113.58M |
| Gross Profit Margin (Quarterly) | 58.80% |
| Profit Margin (Quarterly) | -2.44K% |
| Earnings Yield | -367.5% |
| Normalized Earnings Yield | -343.50 |